全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Giant Cell Tumour of the Skull Base Treated with Surgery, Stereotactic Radiosurgery and Denosumab: Case Report and Review of Literature

DOI: 10.4236/oalib.1103571, PP. 1-7

Subject Areas: Neuroscience

Keywords: Giant Cell Tumour, Skull Base, Stereotactic Radiosurgery, Denosumab

Full-Text   Cite this paper   Add to My Lib

Abstract

Giant cell tumours (GCT) of the skull base account for approximately 1% of all GTC of the bone. Despite being considered as a benign neoplasm, they are locally aggressive with high recurrence rates after incomplete surgery. Due to the small number of cases reported in skull base, standardized treatment remains unclear. Even with new surgical techniques, a complete resection in skull base tumours is not always possible without functional compromise. Therefore, adjuvant therapy is essential to enhance local control and quality of life. We described a case treated successfully with primary surgery followed by Cyberknife stereotactic radiosurgery (SRS) and denosumab with a 48-month follow-up. To the best of our knowledge, the usage of combined therapy, SRS and denosumab, in skull base GCT has not been previously described.

Cite this paper

Guajardo, J. H. , Pena, C. D. L. , Gonzalez, M. F. , Gonzalez, C. , Cuilty, C. and Decanini, H. (2017). Giant Cell Tumour of the Skull Base Treated with Surgery, Stereotactic Radiosurgery and Denosumab: Case Report and Review of Literature. Open Access Library Journal, 4, e3571. doi: http://dx.doi.org/10.4236/oalib.1103571.

References

[1]  Fletcher, C.D.M., Bridge, J.A., Hogendoom, P.C.W., Mertens, F., Eds. (2013) WHO Classification of Tumours of Soft Tissue and Bone. IARC Press, Lyon.
[2]  Sasagawa, Y., Tachibana, O., Shiraga, S., Takata, H., Kinoshita, E., Nojima, T., et al. (2012) Secondary Malignant Giant Cell Tumor of the Clivus: Case Report. Clinical Neurology and Neurosurgery, 114, 786-788.
https://doi.org/10.1016/j.clineuro.2011.12.041
[3]  Zhao, J., Qian, T., Zhi, Z., Li, Q., Kang, L., Wang, J., et al. (2014) Giant Cell Tumor of the Clivus: A Case Report and Review of Literature. Oncology Letters, 8, 2782- 2786.
https://doi.org/10.3892/ol.2014.2528
[4]  Inoue, A., Ohnishi, T., Kohno, S., Nishikawa, M., Nishida, N. and Ohue, S. (2016) Role of Denosumab in Endoscopic Endonasal Treatment for Juvenile Giant Cell Tu- mor: A Case Report and Review of Literature. World Neurosurgery, 91, 674.e1- 674.e6.
https://doi.org/10.1016/j.wneu.2016.04.054
[5]  Gupta, R., Mohindra, S., Mahore, A., Mathuriya, S.N. and Radotra, B.D. (2008) Giant Cell Tumor of the Clivus. British Journal of Neurosurgery, 22, 447-449.
https://doi.org/10.1080/02688690701818943
[6]  Uslu, G.H., Canyilmaz, E., Yoney, A., Aydin, S., Sahbaz, A. and Sari, A. (2014) Giant Cell Tumor of the Occipital Bone: A Case Report and Review of the Literature. Oncology Letters, 8, 151-154.
https://doi.org/10.3892/ol.2014.2086
[7]  Wang, Y., Honda, K., Susuki, S. and Ishikawa, K. (2006) Giant Cell Tumor at the Lateral Skull Base. American Journal of Otolaryngology, 27, 64-67.
https://doi.org/10.1016/j.amjoto.2005.05.021
[8]  Jada, A.S., Shrivastava, R., Mannan, A., Kobets, A. and Manolidis, S. (2015) Rare Presentation of Giant Cell Tumor in the Auditory Canal: Case Report and Review of the Literature. Journal of Neurological Surgery Reports, 76, e65-e71.
https://doi.org/10.1055/s-0034-1396656
[9]  Murphey, M.D., Nomikos, G.C., Flemming, D.J., Gannon, F.H., Temple, H.T. and Kransdorf, M.J. (2001) Imaging of Giant Cell Tumor and Giant Cell Reparative Granuloma of Bone: Radiologic-Pathologic Correlation. Radiogahics, 21, 1283- 1309.
https://doi.org/10.1148/radiographics.21.5.g01se251283
[10]  Colia, V., Provenzano, S., Hindi, N., Casali, P.G. and Stacchiotti, S. (2016) Systemic Therapy for Selected Skull Base Sarcomas: Chondrosarcoma, Chordoma, Giant Cell Tumour and Solitary Fibrous Tumour/Hemangiopericytoma. Reports of Practical Oncology and Radiotherapy, 21, 361-369.
https://doi.org/10.1016/j.rpor.2015.12.005
[11]  Thomas, D., Henshaw, R., Skubitz, K., Chawla, S., Staddon, A., Blay, J.Y., et al. (2010) Denosumab in Patients with Giant-Cell Tumour of Bone: An Open-Label, Phase 2 Study. The Lancet Oncology, 11, 275-280.
https://doi.org/10.1016/S1470-2045(10)70010-3
[12]  Balke, M., Ahrens, H., Streitbuerger, A., Koehler, G., Winkerlmann, W., Gosheger, G., et al. (2009) Treatment Options for Recurrent Giant Cell Tumors of Bone. Jour- nal of Cancer Research and Clinical Oncology, 135, 149-158.
https://doi.org/10.1007/s00432-008-0427-x
[13]  Roeder, F., Timke, C., Zwicker, F., Thieke, C., Bischof, M., Debus, J., et al. (2010) Intensity Modulated Radiotherapy (IMRT) in Benign Cell Tumors: A Single Institution Case Series and Short Review of the Literature. Radiation Oncology, 5, 18.
https://doi.org/10.1186/1748-717X-5-18
[14]  Kim, I.Y., Jung, S., Jung, T.Y., Moon, K.S., Jang, W.Y., Park, S.J., et al. (2012) Gamma Knife Radiosurgery for Giant Cell Tumor of the Petrous Bone. Clinical Neurology and Neurosurgery, 114, 185-189. https://doi.org/10.1016/j.clineuro.2011.10.007
[15]  Saeed, E.F., Tunio, M. and Gabriela, S. (2014) Giant Cell Tumor Of Lumbar Spine Treated with Rapid Arc Intensity Modulated Arc Therapy: Case Report and Review of Literature. Journal of Cancer Research and Therapeutics, 5, 611-617.
https://doi.org/10.4236/jct.2014.56070
[16]  Rutkwoski, P., Ferrari, S., Grimer, R.J., Stalley, P.D., Dijkstra, S.P., Pienkowski, A., et al. (2015) Surgical Downstaging in a Open-Label Phase II Trial of Denosumab in Patients of Giant Cell Tumor of Bone. Annals of Surgical Oncology, 22, 2860-2868.
https://doi.org/10.1245/s10434-015-4634-9
[17]  Chawla, S., Henshaw, R., Seeger, L., Choy, E., Blay, J.Y., Ferrari, S., et al. (2013) Safety and Efficacy of Denosumab for Adults and Skeletally Mature Adolescents with Giant Cell Tumour of Bone: Interim Analysis of an Open-Label, Parallel- Group, Phase 2 Study. The Lancet Oncology, 14, 901-908.
https://doi.org/10.1016/S1470-2045(13)70277-8

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413